Insulin-Like Growth Factor Binding Protein 3

"Insulin-Like Growth Factor Binding Protein 3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

One of the six homologous soluble proteins that bind insulin-like growth factors (SOMATOMEDINS) and modulate their mitogenic and metabolic actions at the cellular level.

Descriptor ID	D018972
MeSH Number(s)	D12.776.157.420.270
Concept/Terms	Insulin-Like Growth Factor Binding Protein 3 Insulin-Like Growth Factor Binding Protein 3 IGF-Binding Protein 3 IGF Binding Protein 3 Protein 3, IGF-Binding IGFBP-3

Below are MeSH descriptors whose meaning is more general than "Insulin-Like Growth Factor Binding Protein 3".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Carrier Proteins [D12.776.157]
Insulin-Like Growth Factor Binding Proteins [D12.776.157.420]
Insulin-Like Growth Factor Binding Protein 3 [D12.776.157.420.270]

Below are MeSH descriptors whose meaning is related to "Insulin-Like Growth Factor Binding Protein 3".

Below are MeSH descriptors whose meaning is more specific than "Insulin-Like Growth Factor Binding Protein 3".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Insulin-Like Growth Factor Binding Protein 3" by people in this website by year, and whether "Insulin-Like Growth Factor Binding Protein 3" was a major or minor topic of these publications.

Bar chart showing 81 publications over 25 distinct years, with a maximum of 8 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1996	1	0	1
1997	2	1	3
1998	1	1	2
1999	1	0	1
2000	1	2	3
2001	1	1	2
2002	4	2	6
2003	3	2	5
2004	4	3	7
2005	4	0	4
2006	4	4	8
2007	0	1	1
2008	3	2	5
2009	2	2	4
2010	0	1	1
2011	3	2	5
2012	3	3	6
2013	1	4	5
2014	0	2	2
2015	0	1	1
2017	2	1	3
2018	0	1	1
2019	0	1	1
2020	2	1	3

Below are the most recent publications written about "Insulin-Like Growth Factor Binding Protein 3" by people in Profiles.

Franciskovich R, Soler-Alfonso C, Neira-Fresneda J, Lupski JR, McCann-Crosby B, Potocki L. Short stature and growth hormone deficiency in a subset of patients with Potocki-Lupski syndrome: Expanding the phenotype of PTLS. Am J Med Genet A. 2020 09; 182(9):2077-2084.

View in: PubMed
Bayraktar S, Baghaki S, Wu J, Liu DD, Gutierrez-Barrera AM, Bevers TB, Valero V, Sneige N, Arun BK. Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study. Cancer Prev Res (Phila). 2020 09; 13(9):795-802.

View in: PubMed
Hight SK, Mootz A, Kollipara RK, McMillan E, Yenerall P, Otaki Y, Li LS, Avila K, Peyton M, Rodriguez-Canales J, Mino B, Villalobos P, Girard L, Dospoy P, Larsen J, White MA, Heymach JV, Wistuba II, Kittler R, Minna JD. An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis. Neoplasia. 2020 08; 22(8):294-310.

View in: PubMed
Crew KD, Anderson GL, Hershman DL, Terry MB, Tehranifar P, Lew DL, Yee M, Brown EA, Kairouz SS, Kuwajerwala N, Bevers T, Doster JE, Zarwan C, Kruper L, Minasian LM, Ford L, Arun B, Neuhouser M, Goodman GE, Brown PH. Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812). Cancer Prev Res (Phila). 2019 07; 12(7):481-490.

View in: PubMed
McCarthy JM, McCann-Crosby BM, Rech ME, Yin J, Chen CA, Ali MA, Nguyen HN, Miller JL, Schaaf CP. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome. J Med Genet. 2018 05; 55(5):307-315.

View in: PubMed
Liao LM, Hofmann JN, Cho E, Pollak MN, Chow WH, Purdue MP. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial. Cancer Causes Control. 2017 Jul; 28(7):801-807.

View in: PubMed
Miles FL, Goodman PJ, Tangen C, Torkko KC, Schenk JM, Song X, Pollak M, Thompson IM, Neuhouser ML. Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial. Nutrients. 2017 Apr 12; 9(4).

View in: PubMed
Capello M, Bantis LE, Scelo G, Zhao Y, Li P, Dhillon DS, Patel NJ, Kundnani DL, Wang H, Abbruzzese JL, Maitra A, Tempero MA, Brand R, Firpo MA, Mulvihill SJ, Katz MH, Brennan P, Feng Z, Taguchi A, Hanash SM. Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. J Natl Cancer Inst. 2017 04 01; 109(4).

View in: PubMed
Liu Z, Chen X, Zhou S, Liao L, Jiang R, Xu J. The histone H3K9 demethylase Kdm3b is required for somatic growth and female reproductive function. Int J Biol Sci. 2015; 11(5):494-507.

View in: PubMed
Paxton RJ, Jung SY, Vitolins MZ, Fenton J, Paskett E, Pollak M, Hays-Grudo J, Hursting SD, Chang S. Associations between time spent sitting and cancer-related biomarkers in postmenopausal women: an exploration of effect modifiers. Cancer Causes Control. 2014 Nov; 25(11):1427-37.

View in: PubMed

People

Explore

Similar Concepts

Top Journals